Phenicarbazide

Summary

Phenicarbazide (CHEMBL1593719) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 151.17 Da · C7H9N3O

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1593719
Name	Phenicarbazide
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	61002
Molecular formula	C7H9N3O
Molecular weight	151.17
InChIKey	AVKHCKXGKPAGEI-UHFFFAOYSA-N

SMILES: C1=CC=C(C=C1)NNC(=O)N

IUPAC name: anilinourea

Also known as: Fenicarbazida, NSC-2763, Phenicarbazide, SID29215327, SID26754487, SID144205185, SID144207246, SID170466385, PHENICARBAZIDE

Patent coverage: 652 distinct patent families (1,189 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).